Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG)

  • H. S. Park
  • , B. Kang
  • , H. J. Chon
  • , H. S. Im
  • , C. K. Lee
  • , I. Kim
  • , M. J. Kang
  • , J. E. Hwang
  • , W. K. Bae
  • , J. Cheon
  • , J. O. Park
  • , J. Y. Hong
  • , J. H. Kang
  • , J. H. Kim
  • , S. H. Lim
  • , J. W. Kim
  • , J. W. Kim
  • , C. Yoo
  • , H. J. Choi

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG)'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science